Goodwin knows that making deals in the healthcare industry a reality comes with significant regulatory and transactional challenges. Our cross-functional healthcare team understands the key regulatory issues and helps clients to navigate regulatory complexity.
Our industry-leading team covers the full spectrum of transactions including private equity investments, mergers and acquisitions, divestitures, public offerings, licensing transactions, the formation of investment partnerships, and the creation of strategic and collaborative alliances and joint ventures. Our industry-focused approach brings lawyers from across disciplines together to advise clients on a variety of complex transactions and novel deal structures.
Goodwin’s healthcare transaction clients benefit from the firm’s global platform that supports growth throughout the entire company lifecycle. Our deep roots in the healthcare industry combined with our FDA regulatory and cybersecurity teams offer clients a distinct competitive advantage. Our dominant market presence across the private equity, life sciences and technology industries supports our clients’ expansion and convergence and helps our clients navigate rapidly evolving healthcare demands. As the healthcare system continues to converge, we connect clients with strategic partners and resources from inception to IPO or exit.